groovebipharma1

MicroRNA startup Groove Biopharma scores $6 million

It’s been a bit slow in Seattle venture capital circles in the past few months. But some of the region’s leading biotech investors are doing their part to pick up the pace as Groove Biopharma today is announcing $6 million in second round of financing. Backers of the company, housed at the biotech business incubator… Read More

theraclone11

Theraclone Sciences raises $10M

Theraclone Sciences, a Seattle biotechnology company that’s developing a method to rapidly identify disease-fighting antivbodies, has attracted $10.6 million. Investors in the deal include ARCH Venture Partners, Canaan Partners, MPM Capital, Healthcare Ventures, Alexandria Real Estate Equities, Amgen Ventures and Zenyaku Kogyo “The anticipated near-term initiation of Theraclone’s first clinical trial and our discovery collaboration with Pfizer earlier… Read More

impinj1

Impinj files for $100 million IPO

For the second time this week, a Seattle technology company has filed to go public. This time it is Impinj, the maker of radio frequency identification technologies. The company said in a filing today with the SEC that it plans to raise up to $100 million through the offering. The filing comes just a few… Read More